Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769298 · ClinicalTrials.gov registry record · Phase 2
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
A Phase 2 study of Kidney Pancreas Transplantation, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03769298 is a Phase 2 study of Kidney Pancreas Transplantation that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03769298, a Phase 2 study of Kidney Pancreas Transplantation, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.
Conditions Studied
Interventions
- DRUG Envarsus XR
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03769298
The ClinicalTrials.gov registry entry for NCT03769298 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Pancreas Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Envarsus XR is the first listed.
NCT03769298 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03769298 about?
NCT03769298 is a clinical study titled "CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients". This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.
What is the current status of trial NCT03769298?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2019-02-27. Estimated completion is 2026-12.
What conditions does trial NCT03769298 study?
This clinical trial studies the following conditions: Kidney Pancreas Transplantation.
What interventions are being tested in trial NCT03769298?
The interventions under investigation include: Envarsus XR (DRUG).
Who is sponsoring clinical trial NCT03769298?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03769298 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.